Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CBAN
CBAN logo

CBAN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Colony Bankcorp Inc (CBAN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
19.710
1 Day change
0.56%
52 Week Range
21.460
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Colony Bankcorp Inc (CBAN) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows positive insider buying trends, solid financial growth in the latest quarter, and favorable analyst ratings. While technical indicators are neutral, the lack of significant negative catalysts and the positive sentiment from analysts make it a suitable long-term investment.

Technical Analysis

The MACD is below 0 and negatively contracting, indicating a bearish trend. RSI is neutral at 39.947, and moving averages are converging, showing no clear trend. Key support is at 19.598, and resistance is at 20.809.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
5

Positive Catalysts

  • Insiders are buying with a significant 181.38% increase in the last month. Analysts have initiated positive coverage with price targets of $26 and $31, citing strong credit, low deposit costs, and excess capital for acquisitions. Financials show revenue growth of 18.62% YoY and net income growth of 5.53% YoY.

Neutral/Negative Catalysts

  • No recent news or significant hedge fund activity. Technical indicators are neutral to slightly bearish, and there is no recent congress trading data.

Financial Performance

In Q4 2025, revenue increased by 18.62% YoY to $33.74M, net income rose by 5.53% YoY to $7.84M, and EPS remained flat at 0.42. Gross margin showed no change.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have initiated coverage with a Market Perform rating and a $26 price target (Keefe Bruyette) and an Overweight rating with a $31 price target (Morgan Stanley). The stock is considered high-quality with strong fundamentals and acquisition potential.

Wall Street analysts forecast CBAN stock price to rise
Analyst Rating
0
Wall Street analysts forecast CBAN stock price to rise
Buy
Hold
Sell
0
Current: 19.600
sliders
Low
0
Averages
0
High
0
0
Current: 19.600
sliders
Low
0
Averages
0
High
0
Keefe Bruyette
Market Perform
initiated
$26
AI Analysis
2025-12-15
Reason
Keefe Bruyette
Price Target
$26
AI Analysis
2025-12-15
initiated
Market Perform
Reason
Keefe Bruyette initiated coverage of Central Bancompany with a Market Perform rating and $26 price target.
Morgan Stanley
Overweight
initiated
$31
2025-12-15
Reason
Morgan Stanley
Price Target
$31
2025-12-15
initiated
Overweight
Reason
Morgan Stanley initiated coverage of Central Bancompany with an Overweight rating and $31 price target. The firm says Central is a high-quality bank with low deposit costs, strong credit, and "peer-leading" excess capital. The market should give the stock more credit for the bank's excess capital as it is deployed into acquisitions, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CBAN
Unlock Now

People Also Watch